These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 29169588

  • 1. Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study.
    Vita R, Settineri S, Liotta M, Benvenga S, Trimarchi F.
    Maturitas; 2018 Jan; 107():92-96. PubMed ID: 29169588
    [Abstract] [Full Text] [Related]

  • 2. Physical changes, laboratory parameters, and bone mineral density during testosterone treatment in adolescents with gender dysphoria.
    Stoffers IE, de Vries MC, Hannema SE.
    J Sex Med; 2019 Sep; 16(9):1459-1468. PubMed ID: 31405768
    [Abstract] [Full Text] [Related]

  • 3. Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.
    Hashemi L, Marijic Buljubasic A, Budoff MJ, Copeland LA, Jackson NJ, Jasuja GK, Gornbein J, Reue K.
    JAMA Netw Open; 2024 Jul 01; 7(7):e2419696. PubMed ID: 38954413
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of hormonal and mental treatments with MMPI in FtM individuals: cross-sectional and longitudinal studies.
    Oda H, Kinoshita T.
    BMC Psychiatry; 2017 Jul 17; 17(1):256. PubMed ID: 28716082
    [Abstract] [Full Text] [Related]

  • 5. The role of androgens in transgender medicine.
    Dimakopoulou A, Millar OD, Moschonas D, Jayasena CN.
    Best Pract Res Clin Endocrinol Metab; 2022 Sep 17; 36(5):101617. PubMed ID: 35120800
    [Abstract] [Full Text] [Related]

  • 6. Cross-sex hormonal treatment and body uneasiness in individuals with gender dysphoria.
    Fisher AD, Castellini G, Bandini E, Casale H, Fanni E, Benni L, Ferruccio N, Meriggiola MC, Manieri C, Gualerzi A, Jannini E, Oppo A, Ricca V, Maggi M, Rellini AH.
    J Sex Med; 2014 Mar 17; 11(3):709-19. PubMed ID: 24330520
    [Abstract] [Full Text] [Related]

  • 7. Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals.
    Mueller A, Haeberle L, Zollver H, Claassen T, Kronawitter D, Oppelt PG, Cupisti S, Beckmann MW, Dittrich R.
    J Sex Med; 2010 Sep 17; 7(9):3190-8. PubMed ID: 20584125
    [Abstract] [Full Text] [Related]

  • 8. Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis.
    Tack LJ, Craen M, Dhondt K, Vanden Bossche H, Laridaen J, Cools M.
    Biol Sex Differ; 2016 Sep 17; 7():14. PubMed ID: 26885361
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents.
    Tack LJW, Heyse R, Craen M, Dhondt K, Bossche HV, Laridaen J, Cools M.
    J Sex Med; 2017 May 17; 14(5):747-757. PubMed ID: 28499525
    [Abstract] [Full Text] [Related]

  • 11. Effects of gender affirming hormone treatment in transgender individuals - a retrospective cohort study.
    Muir CA, Guttman-Jones M, Man EJ.
    Endocrine; 2024 Jul 17; 85(1):370-379. PubMed ID: 38386168
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy: A Narrative Review.
    Streed CG, Harfouch O, Marvel F, Blumenthal RS, Martin SS, Mukherjee M.
    Ann Intern Med; 2017 Aug 15; 167(4):256-267. PubMed ID: 28738421
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cross-Sex Hormones and Metabolic Parameters in Adolescents With Gender Dysphoria.
    Jarin J, Pine-Twaddell E, Trotman G, Stevens J, Conard LA, Tefera E, Gomez-Lobo V.
    Pediatrics; 2017 May 15; 139(5):. PubMed ID: 28557738
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Link between Estradiol and Neuroplasticity in Transgender Women after Gender-Affirming Surgery: A Bimodal Hypothesis.
    Schneider MA, Spritzer PM, Suh JS, Minuzzi L, Frey BN, Schwarz K, Costa AB, da Silva DC, Garcia CCG, Fontanari AMV, Anes M, Castan JU, Cunegatto FR, Picon FA, Luders E, Lobato MIR.
    Neuroendocrinology; 2020 May 15; 110(6):489-500. PubMed ID: 31461715
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.